Pasar al contenido principal

EL AUMENTO EN LA S-SUFIHIDRACION DE CISTEINAS PROMOVIDA POR GENERADORES INTRACELULARES DEL SULFURO DE HIDROGENO COMO ESTRATEGIA PARA CONSEGUIR UN ENVEJECIMIENTO MAS SALUDABLE

PID2021-123965OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Generation of mesenchymal stromal cells from urine-derived iPSCs of pediatric brain tumor patients

  • Baliña-Sánchez, Carmen
  • Aguilera García, Yolanda
  • Adán, Norma
  • Sierra-Párraga, Jesús María
  • Olmedo-Moreno, Laura
  • Panadero-Morón, Concepción
  • Cabello-Laureano, Rosa
  • Márquez-Vega, Catalina
  • Martín-Montalvo, Alejandro
  • Capilla-González, Vivian
Human induced pluripotent stem cells (iPSCs) provide a virtually inexhaustible source of starting material for next generation cell therapies, offering new opportunities for regenerative medicine. Among different cell sources for the generation of iPSCs, urine cells are clinically relevant since these cells can be repeatedly obtained by non-invasive methods from patients of any age and health condition. These attributes encourage patients to participate in preclinical and clinical research. In particular, the use of urine-derived iPSC products is a convenient strategy for children with brain tumors, which are medically fragile patients. Here, we investigate the feasibility of using urine samples as a source of somatic cells to generate iPSC lines from pediatric patients with brain tumors (BT-iPSC). Urinary epithelial cells were isolated and reprogrammed using non-integrative Sendai virus vectors harboring the Yamanaka factors KLF4, OCT3/4, SOX2 and C-MYC. After reprogramming, BT-iPSC lines were subject to quality assessment and were compared to iPSCs obtained from urine samples of non-tumor pediatric patients (nonT-iPSC). We demonstrated that iPSCs can be successfully derived from a small volume of urine obtained from pediatric patients. Importantly, we showed that BT-iPSCs are equivalent to nonT-iPSCs in terms of morphology, pluripotency, and differentiation capacity into the three germ layers. In addition, both BT-iPSCs and nonT-iPSCs efficiently differentiated into functional mesenchymal stem/stromal cells (iMSC) with immunomodulatory properties. Therefore, this study provides an attractive approach to non-invasively generate personalized iMSC products intended for the treatment of children with brain tumors., This research was funded by the Institute of Health Carlos III, cofounded by Fondos FEDER (CP19/00046 and PI20/00341 to VC-G), the Asociación Pablo Ugarte (+VIDA project to VC-G), the Asociación Española Contra el Cancer (IDEAS20051CAPI to VCG), the Consejería de Transformación Económica, Industria, Conocimiento y Universidades of Junta de Andalucia, co-funded by Fondos FEDER (PY20/00481 to VC-G and PY20/00480 to AM-M) and the Spanish Ministry of Science and Innovation (PID2021-123965OB-I00 to AM-M). LO-M receives the support of the Spanish Ministry of Universities (FPU19/04703). JMS-P is supported by the Consejerı́a de Transformación Económica, Industria, Conocimiento y Universidades of Junta de Andalucia, co-funded by Fondos FEDER (POSTDOC/21/00424).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Hydroxycitrate delays early mortality in mice and promotes muscle regeneration while inducing a rich hepatic energetic status

  • Espadas Villanueva, Isabel
  • Cáliz-Molina, María Ángeles
  • López-Fernández-Sobrino, Raúl
  • Panadero-Morón, Concepción
  • Sola-García, Alejandro
  • Soriano-Navarro, Mario
  • Martínez-Force, Enrique
  • Venegas-Calerón, Mónica
  • Salas, Joaquín J.
  • Martín, Franz
  • Gauthier, Benoit R.
  • Alfaro-Cervelló, Clara
  • Martí-Aguado, David
  • Capilla-González, Vivian
  • Martín-Montalvo, Alejandro
16 Páginas.-- 6 Figuras, ATP citrate lyase (ACLY) inhibitors have the potential of modulating central processes in protein, carbohydrate, and lipid metabolism, which can have relevant physiological consequences in aging and age-related diseases. Here, we show that hepatic phospho-active ACLY correlates with overweight and Model for End-stage Liver Disease score in humans. Wild-type mice treated chronically with the ACLY inhibitor potassium hydroxycitrate exhibited delayed early mortality. In AML12 hepatocyte cultures, the ACLY inhibitors potassium hydroxycitrate, SB-204990, and bempedoic acid fostered lipid accumulation, which was also observed in the liver of healthy-fed mice treated with potassium hydroxycitrate. Analysis of soleus tissue indicated that potassium hydroxycitrate produced the modulation of wound healing processes. In vivo, potassium hydroxycitrate modulated locomotor function toward increased wire hang performance and reduced rotarod performance in healthy-fed mice, and improved locomotion in mice exposed to cardiotoxin-induced muscle atrophy. Our findings implicate ACLY and ACLY inhibitors in different aspects of aging and muscle regeneration., This work was funded by grants from the Ministerio de Ciencia e Innovación (PID2021-123965OB-100), Junta de Andalucía (P20_00480), the Spanish Society of Diabetes and CSIC (202220I059) to AMM and the Institute of Health Carlos III, co funded by Fondos FEDER (CP19/00046, PI23/00315, and PI20/00341) to VCG. We acknowledge the support of the group of basic research on diabetes of the Spanish Society of Diabetes and the CIBERDEM of the ISCIII., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Glioblastoma progression is hindered by melatonin-primed mesenchymal stromal cells through dynamic intracellular and extracellular reorganizations

  • Olmedo-Moreno, Laura
  • Panadero-Morón, Concepción
  • Sierra-Párraga, Jesús María
  • Bueno-Fernández, Rubén
  • Norton, Emily S.
  • Aguilera García, Yolanda
  • Mellado-Damas, Nuria
  • García-Tárraga, Patricia
  • Morales-Gallel, Raquel
  • Antequera-Martínez, María
  • Durán, Raúl V.
  • Ferrer-Lozano, Jaime
  • Escames, Germaine
  • García-Verdugo, José Manuel
  • Martín-Montalvo, Alejandro
  • Guerrero-Cázares, Hugo
  • Capilla-González, Vivian
Rationale: Glioblastoma (GBM) is the most fatal form of brain cancer and its treatment represents a persistent challenge. Mesenchymal stromal cells (MSCs) have been explored as therapeutic tools in cancer management owing to their tumor-homing abilities. However, their clinical application is limited due to the controversial role of MSCs in carcinogenesis. This study investigates how MSCs influence tumor behavior and explores the synergistic anticancer effects in combination with melatonin (Mel). Methods: Orthotopic and subcutaneous GBM xenograft mouse models were used to assess the antitumor effect of Mel pre-treated MSCs (MSCMel). Histological, immunohistochemical, and ultrastructural analyses were conducted to identify phenotypic changes in tumors. Through a set of in vitro assays, including direct and indirect co-cultures, dynamic single-cell tracking and tumorsphere assay, we explored the impact of MSCMel on primary and non-primary GBM cells. Transcriptomic profiling was used to identify genes and pathways modulated by this synergistic therapy. Results: MSCMel delayed tumor growth in mice and increased collagen deposition. Additionally, MSCMel showed enhanced capacity to prevent GBM cell migration compared to untreated MSCs. Molecular analysis identified genes and proteins related to cell migration, cytoskeletal dynamics and extracellular matrix remodeling in GBM cells exposed to MSCMel, including reduced vimentin expression. Finally, a genetic signature associated with the clinical outcomes of GBM patients was identified. Conclusions: Our study demonstrates that melatonin enhances the anticancer properties of MSCs, providing new insights into their interaction with GBM cells and tumor environment. These findings offer valuable guidance for advancing MSC-based therapies in clinical practice., This research was funded by the Institute of Health Carlos III, co-funded by Fondos FEDER (PI23/00315, PI20/00341 and CP19/00046 to VC-G) and the Asociación Española Contra el Cancer (IDEAS20051CAPI to VC-G). LO-M is supported by the Spanish Ministry of Science, Innovation and Universities (FPU19/04703). JMS-P was supported by the Consejería de Transformación Económica, Industria, Conocimiento y Universidades of Junta de Andalucia, co-funded by Fondos FEDER (POSTDOC/21/00424) and the Institute of Health Carlos III, co-funded by Eropean Union (CD23/00104). CP-M is supported by the Asociación Pablo Ugarte. RM-G is supported by the Asociación Española Contra el Cancer (PRDVA222457MORA). RV-D. was supported by Grant PID2021- 124251OB-I00 and Grant RED2022-134927-T funded by MICIU/AEI/10.13039/501100011033 and by ERDF/UE. AM-M is supported by the Ministerio de Ciencia e Innovación (PID2021-123965OB-100). HG-C is supported by the National Institute of Neurological Disorders and Stroke and internal Mayo Clinic funds. JMG-V was supported by the Valencian Council for Education, Culture, University and Employment (CIPROM/2023/053)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Tesis doctoral (DoctoralThesis)

Evaluation of the modulation of the intracellular production of hydrogen sulfide as a therapeutic weapon to promote healthy aging

  • Cáliz-Molina, María Ángeles
Trabajo presentado para lograr el título de Doctor por la Universidad de Sevilla, Bioquímica Médica y Biología Molecular e Inmunología, Aging is a major driving force behind metabolic decline, loss of functionality and death. There are redox-active metabolite that plays a critical role in cellular metabolism. The proposed biological actions of H2S include the post-translational modulation of enzymes through protein persulfidation, antioxidant capacity, and as a substrate for the mitochondrial electron transport chain. Remarkably, we discovered that certain compounds in mice improve healthspan in male mice. Conversely, studies in human plasma show that post-translational modifications correlate with certain parameters of health. Thus, our results support the potential use of compounds to promote healthy aging., This work was funded by grants from the Ministerio de Ciencia e Innovación (PID2021- 123965OB-100 MCIN/590214 ERDF), Junta de Andalucía (P20_00480), Spanish Society of Diabetes and CSIC (202220I059). We acknowledge the support of the group of basic research on diabetes of the Spanish Society of Diabetes and the CIBERDEM of the ISCIII. María Ángeles Cáliz received a PhD grant, which support this work over four years, through the predoctoral Grant FPU19 / 054680 funded by MCIN/AEI/ 10.13039/501100011033 under the slogan “ESF Investing in your future” and was accepted in the ANEP BIOMEDICINE #BMED-25.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Protocol for assessing enzymatic and non-enzymatic hydrogen sulfide production and levels

  • Cáliz-Molina, María Ángeles
  • Pino-Pérez, Inmaculada
  • Ponti, András K.
  • Hine, Christopher
  • Martín-Montalvo, Alejandro
Hydrogen sulfide (H2S) is a key molecule in metabolism with important physiological effects. Despite its merits, detection and/or accurate determination remain challenging. Here, we present a protocol to determine H2S levels and cumulative production using a microsulfide ion electrode and lead acetate paper. We describe steps for measurement of H2S levels, as well as detection of enzymatic and non-enzymatic cumulative H2S production across various biological contexts. This protocol is thus compatible with H2S donors, tissue samples, and live cultured cells. For complete details on the use and execution of this protocol, please refer to Caliz-Molina et al.1., This work was funded by the Ministerio de Ciencia e Innovación/AEI/10.13039/501100011033 and FEDER, a way of making Europe; FSE invest in your future (PID2021-123965OB-100 and PID2024-156080OB-I00 to A.M.-M., FPU19/05468 to M.A.C.-M., and FPU21/01338 to I.P.-P.); and Junta de Andalucía of public funding, in the 2024 call of the Consejería de Salud y Consumo for the financing of research, development, and innovation (R&D&I) in Biomedicine and Health Sciences in Andalusia (PI-003502024 to A.M.-M). We acknowledge the support of the Basic Research Group of the Spanish Society of Diabetes, CIBERDEM and the Conexión COMETA of CSIC., Peer reviewed